Abstract:Objective: Autoimmune target tissues in type 1 diabetes include pancreatic β-cells and peri-islet Schwann cells (pSC)--the latter active participants or passive bystanders in pre-diabetic autoimmune progression. To distinguish between these alternatives, we sought to suppress pSC autoimmunity by transgenic expression of the negative costimulatory molecule B7-H1 in NOD pSC. Research design and methods: A B7-H1 transgene was placed under control of the glial fibrillary acidic protein (GFAP) promoter. Transgenic and wild-type NOD mice were compared for transgene PD-1 affinities, diabetes development, insulitis, and pSC survival. Mechanistic studies included adoptive type 1 diabetes transfer, B7-H1 blockade, and T-cell autoreactivity and sublineage distribution. Results: Transgenic and endogenous B7-H1 bound PD-1 with equal affinities. Unexpectedly, the transgene generated islet-selective CD8(+) bias with accelerated rather than suppressed diabetes progression. T-cells of diabetic transgenics transferred type 1 diabetes faster. There were no earlier pSC losses due to conceivable transgene toxicity, but transgenic pSC loss was enhanced by 8 weeks, preceded by elevated GFAP autoreactivity, with high-affinity T-cells targeting the major NOD K(d)-GFAP epitope, p253-261. FoxP3(+) regulatory T- and CD11c(+) dendritic cell pools were unaffected. Conclusions: In contrast with transgenic B7-H1 in NOD mouse β-cells, transgenic B7-H1 in pSC promotes rather than protects from type 1 diabetes. Here, ectopic B7-H1 enhanced the pathogenicity of effector T-cells, demonstrating that pSC can actively impact diabetes progression-likely through modification of intraislet T-cell selection. Although pSC cells emerge as a new candidate for therapeutic targets, caution is warranted with regard to the B7-H1-PD1 axis, where B7-H1 overexpression can lead to accelerated autoimmune disease.

Is innervation an early target in autoimmune diabetes?

Remodeling of the innervation of pancreatic islets accompanies insulitis preceding onset of diabetes in the NOD mouse

Autoimmune islet destruction in spontaneous type 1 diabetes is not beta-cell exclusive

Pancreatic ductal cell antigens are important in the development of invasive insulitis in Non-Obese Diabetic mice

Targeting of pancreatic glia in type 1 diabetes

Innate Immunity in Type 1 Diabetes

Network approach reveals preferential T-cell and macrophage association with α-linked β-cells in early stage of insulitis in NOD mice

Insulin-dependent diabetes in the NOD mouse model. I. Detection and characterization of autoantibody bound to the surface of pancreatic beta cells prior to development of the insulitis lesion in prediabetic NOD mice

Crinophagic granules in pancreatic β cells contribute to mouse autoimmune diabetes by diversifying pathogenic epitope repertoire

Role of Innate Immune Cells in Type 1 Diabetes Mellitus

The Contribution of Neutrophils and NETs to the Development of Type 1 Diabetes

Unexpected acceleration of type 1 diabetes by transgenic expression of B7-H1 in NOD mouse peri-islet glia

CD4+ T cells reactive to a hybrid peptide from insulin-chromogranin A adopt a distinct effector fate and are pathogenic in autoimmune diabetes

Presumption of innocence for beta cells: why are they vulnerable autoimmune targets in type 1 diabetes?

Immune perturbations in human pancreas lymphatic tissues prior to and after type 1 diabetes onset

Cellular and molecular pathogenic mechanisms of insulin-dependent diabetes mellitus

Macrophages protect against sensory axon degeneration in diabetic neuropathy

B lymphocyte "original sin" in the bone marrow enhances islet autoreactivity in type 1 diabetes-prone nonobese diabetic mice

Type 1 diabetes mellitus as a disease of the β-cell (do not blame the immune system?)

The Extra-Islet Pancreas Supports Autoimmunity in Human Type 1 Diabetes

Innate immune stimulation of whole blood reveals IFN-1 hyper-responsiveness in type 1 diabetes